11 Most Undervalued Growth Stocks to Buy According to Hedge Funds

Page 10 of 10

​1. Merck & Co., Inc. (NYSE:MRK)

Forward P/E Ratio: 9.01

Number of Hedge Fund Holders: 92

​Merck & Co., Inc. (NYSE:MRK) is one of the Most Undervalued Growth Stocks to Buy According to Hedge Funds. On September 19, Merck & Co., Inc. (NYSE:MRK) announced that its ENFLONSIA has received a positive recommendation from the European Medicines Agency’s Committee for Medicinal Products for Human Use.

​The approval is for preventing respiratory syncytial virus lower respiratory tract disease in newborns and infants during their first RSV season. Management noted that they now await review by the European Commission for marketing authorization in the EU, Iceland, Liechtenstein, and Norway, with a final decision expected by the end of 2025.

​The endorsement is based on results from two clinical trials, CLEVER and SMART, which showed ENFLONSIA significantly reduced RSV infections and hospitalizations compared to placebo.

Merck & Co., Inc. (NYSE:MRK) is a global healthcare company that develops and sells prescription medicines, vaccines, and biologic therapies for human health.

While we acknowledge the potential of MRK to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than MRK and that has 100x upside potential, check out our report about this cheapest AI stock.

READ NEXT: The Best and Worst Dow Stocks for the Next 12 Months and 10 Unstoppable Stocks That Could Double Your Money.

Disclosure: None. Insider Monkey focuses on uncovering the best investment ideas of hedge funds and insiders. Please subscribe to our free daily e-newsletter to get the latest investment ideas from hedge funds’ investor letters by entering your email address below.

Page 10 of 10